Chemical giant Chemours delays quarterly earnings release, internal review underway
Citing ‘woke culture,’ Chemours director resigns over abortion benefits for employees
Stocks making the biggest moves in the premarket: Hibbett, Silvergate Capital, Chemours and more
Einhorn's Greenlight exited Chemours, Playboy and Warner Bros Discovery in Q3
2.64BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1638511089
CUSIP
163851108
Sector
Basic Materials
Industry
Specialty Chemicals
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
35.28
PEG Ratio
1.67
Book Value
4.40
Dividend Share
1
Dividend Yield
5.67%
Earnings Share
0.5
Wall Street Target Price
23.7778
EPS Estimate Current Year
1.2315
EPS Estimate Next Year
2.1122
EPS Estimate Current Quarter
0.28
EPS Estimate Next Quarter
0.27
Most Recent Quarter
-
Revenue TTM
5,749,000,192
Gross Profit TTM
1,132,999,936
EBITDA
786,000,000
Profit Margin
1.32%
Return On Assets TTM
3.97%
Return On Equity TTM
11.02%
Revenue Per Share TTM
38.519
Qtly Revenue Growth YOY
0.90%
Diluted Eps TTM
0.5
Qtly Earnings Growth YOY
-64.60%
Trailing PE
35.28
Forward PE
6
Price Sales TTM
0.4584
Price Book MRQ
4.0116
Enterprise Value Revenue
1
Enterprise Value EBITDA
10
307.96
2.04%428.41
1.68%341.70
1.65%161.10
0.72%4164.00
0.26%233.90
0.19%32.06
0.00%0.51
0.00%238.18
-2.18%84.33
-0.60%